Back to search
FDAFDA · Food and drugs·Recall number Z-1784-2017

Cataract Kit - Dr. Slingsby, part number CMP1017(B. Product packaged in a convenient manner for use in a general clinical procedure

Published April 19, 2017 · Recall initiated: March 16, 2017

Summary

FDA records medical device Class II recall Z-1784-2017, published April 19, 2017 and initiated March 16, 2017. Recalling firm: Windstone Medical Packaging, Inc.; Status: Terminated; Reported quantity: 990 kits; Lot: Lot numbers: 77429 79999 81143 81960 84055 84556 85169 85550 86501 87632 87819 96056 96963 97873 98741 99416 99763 100278 101449. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

AMS custom kits containing Medtronic Covidien Curity Eye Pad are recalled due to the potential for the sterile packaging of the eye pad to be compromised.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Windstone Medical Packaging, Inc.
Distributor
Nationwide Distribution including CA, CO, FL, GA, IA, KY, MA, MN, MO, ND, NJ, NV, OH, SD, TX, UT, WI, and WY.
Lot
Lot numbers: 77429 79999 81143 81960 84055 84556 85169 85550 86501 87632 87819 96056 96963 97873 98741 99416 99763 100278 101449
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Cataract Kit - Dr. Slingsby, part number CMP1017(B. Product packaged in a convenient manner for use in a general clinical procedure recalled?

Yes. FDA published recall Z-1784-2017 on April 19, 2017. Reported hazard: AMS custom kits containing Medtronic Covidien Curity Eye Pad are recalled due to the potential for the sterile packaging of the eye pad to be compromised.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit